VS
Vinit Singh
Hematology & Oncology
Credentials: · ·
History
- 2023–2026
Hematology and Medical Oncology
- 2020–2023
- 2016–2020
Medical School
Research
Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series
Case report · Journal of Medical Cases · 2022 · 17 citations
Journal of Hematology · 2022 · 13 citations
World Journal of Oncology · 2022 · First of 7 authors · 10 citations

6 papers · 6 as a fellow
- DG
4 papers · 4 as a resident
- ML
3 papers
- TM
3 papers

3 papers

3 papers
- AR
2 papers

2 papers · 1 as a fellow

